Showing results (1151-1160 of 1,581) with videos related to

Sort By:
Pageof 159
Pharmaceutics|February 26, 2022
Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing BacteriaPhuoc Vinh Nguyen, Clémentine Aubry, Narimane Boudaoud, et al.
Bulletin Du Cancer|November 12, 2003
[Tumor/cytotoxic effector cross-talk in the control of tumor susceptibility to lysis]Asma Gati, Guillaume Dorothée, Jérôme Thiéry, et al.
The Journal of Cell Biology|October 24, 2012
Critical role for the kinesin KIF3A in the HIV life cycle in primary human macrophagesRaphaël Gaudin, Bruna Cunha de Alencar, Mabel Jouve, et al.
Plos One|September 13, 2012
Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancerCarine Bossard, Muriel Busson, David Vindrieux, et al.
Scandinavian Journal of Gastroenterology|May 6, 2004
The burden cost of French patients suffering from irritable bowel syndromeC Le Pen, P Ruszniewski, A F Gaudin, et al.
RSC Advances|May 6, 2022
Nucleoside-lipid-based nanocarriers for methylene blue delivery: potential application as anti-malarial drugKoffi Kowouvi, Bruno Alies, Mathieu Gendrot, et al.
Protist|March 12, 2013
Inheritance of mitochondrial DNA in the Pennate diatom Haslea ostrearia (Naviculaceae) during auxosporulation suggests a uniparental transmissionRomain Gastineau, Vincent Leignel, Boris Jacquette, et al.
Nature Nanotechnology|July 30, 2013
Symmetry and magnitude of spin-orbit torques in ferromagnetic heterostructuresKevin Garello, Ioan Mihai Miron, Can Onur Avci, et al.
Pharmacoeconomics - Open|July 4, 2024
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in FrancePaul Casabianca, Marc Massetti, François-Emery Cotte, et al.
GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW|August 1, 2022
New and innovative biomaterials, techniques and therapy concepts: Biologization in maxillofacial surgery, oral surgery and dentistry is in full swing. PRF, PRGF, PRP, blood plasma-stabilized augmentations, supplementation of micronutrients and vitamins - what opportunities do such "biological" approaches actually offer? We introduce them hereRalf Smeets, Anders Henningsen, Oliver Zernial, et al.
Pageof 159